CMR Surgical Appoints Massimiliano Colella as CEO
Portfolio - People | Jan 14, 2025 | Lightrock
CMR Surgical, a company innovating robotic-assisted surgical devices, has received U.S. FDA Marketing Authorization for its new Versius Surgical System, targeted at performing cholecystectomy through minimally invasive means. This next-generation device is designed to biomimic human arm movement, offering optimal port placement, enhanced dexterity, and improved precision. The modular and portable design intends to meet the diverse needs of surgical settings, ensuring a seamless fit into existing workflows without necessitating changes in hospital infrastructure. Alongside this breakthrough, the company has strengthened its leadership team with the appointment of Massimiliano Colella as CEO, Markus Bauman as Chief Legal & Business Affairs Officer, and Daniel Moore as Non-Executive Chairman as it gears to solidify its market presence. Versius's training pathways leverage virtual reality and other platforms to ensure skilled surgeons swiftly adapt to this technology. Supported by the private equity firm Lightrock, CMR Surgical is positioned at a pivotal juncture to expand its innovative solutions in the U.S. healthcare landscape.
Sectors
- Healthcare Technology
- Medical Devices
- Private Equity
Geography
- United States – The FDA Marketing Authorization pertains to the U.S. market where CMR Surgical is seeking to expand the use of its Versius Surgical System.
- United Kingdom – CMR Surgical is headquartered in the UK and the developments in the article, including leadership appointments, are relevant to its operations there.
Industry
- Healthcare Technology – CMR Surgical is innovating in the healthcare technology sector with its Versius Surgical System designed for minimally invasive surgeries.
- Medical Devices – The article discusses the Versius Surgical System, a medical device intended for surgical procedures, highlighting advancements in this industry.
- Private Equity – Lightrock, a private equity firm, is backing CMR Surgical, showcasing the firm's involvement in healthcare technology investments.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| CMR Surgical | Target company | Company | A UK-based medical device company innovating in robotic surgical systems. |
| Massimiliano Colella | New Chief Executive Officer | Person | Recently appointed CEO of CMR Surgical. |
| Markus Bauman | Chief Legal & Business Affairs Officer | Person | Recently appointed to CMR Surgical's executive leadership team. |
| Daniel Moore | Non-Executive Chairman | Person | Appointed as Non-Executive Chairman at CMR Surgical. |
| Lightrock | Private Equity Firm | Company | A private equity firm invested in CMR Surgical. |
| U.S. Food and Drug Administration (FDA) | Regulatory Body | Government | Granted marketing authorization for Versius Surgical System in the U.S. |